Tirzepatide

New diabetes drug

eAwaz Medicine

London – A new study shows that weekly intake of a drug can substantially reduce body weight. The drug is approved to treat Type 2 diabetes. Last month the US Food and Drug Administration approved Tirzepatide, under the trade name Mounjaro, for the treatment of Type 2 diabetes. Currently, Tirzepatide is not available for weight loss, but Eli Lilly is aiming to get an updated timeline from the FDA this year.